{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:24:54Z","timestamp":1789683894544,"version":"4.0.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00059-025-05296-z","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T11:33:18Z","timestamp":1741865598000},"page":"96-102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pr\u00e4zisionsmedizin bei Diagnostik und Therapie von Kardiomyopathien","Precision medicine in the diagnostics and treatment of cardiomyopathies"],"prefix":"10.1007","volume":"50","author":[{"given":"Niklas","family":"Vetter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Meder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"5296_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5334\/gh.1288","volume":"19","author":"M Di Cesare","year":"2024","unstructured":"Di Cesare\u00a0M et\u00a0al (2024) The heart of the world. Glob Heart 19:11","journal-title":"Glob Heart"},{"key":"5296_CR2","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/S0140-6736(57)90159-9","volume":"273","author":"W Brigden","year":"1957","unstructured":"Brigden\u00a0W (1957) Uncommon myocardial diseases; the non-coronary cardiomyopathies. Lancet 273:1179\u20131184","journal-title":"Lancet"},{"key":"5296_CR3","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","volume":"44","author":"E Arbelo","year":"2023","unstructured":"Arbelo\u00a0E et\u00a0al (2023) 2023 ESC guidelines for the management of cardiomyopathies. Eur Heart\u00a0J 44:3503\u20133626","journal-title":"Eur Heart J"},{"key":"5296_CR4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","volume":"29","author":"P Elliott","year":"2007","unstructured":"Elliott\u00a0P et\u00a0al (2007) Classification of the cardiomyopathies: a\u00a0position statement from the european society of cardiology working group on myocardial and pericardial diseases. Eur Heart\u00a0J 29:270\u2013276","journal-title":"Eur Heart J"},{"key":"5296_CR5","unstructured":"Meder LE et\u00a0al (2023) DGK Pocket-Leitlinie: Kardiomyopathien. https:\/\/leitlinien.dgk.org\/files\/33_2023_pocket_leitlinien_kardiomyopathien.pdf;. Zugegriffen: 1. Nov. 2023"},{"key":"5296_CR6","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/ehjci\/jez178","volume":"20","author":"E Donal","year":"2019","unstructured":"Donal\u00a0E et\u00a0al (2019) Multimodality imaging in the diagnosis, risk stratification, and management of patients with dilated cardiomyopathies: an expert consensus document from the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging 20:1075\u20131093","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"5296_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang\u00a0RM et\u00a0al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. J\u00a0Am Soc Echocardiogr 28:1\u201339.e14","journal-title":"J Am Soc Echocardiogr"},{"key":"5296_CR8","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","volume":"43","author":"K Zeppenfeld","year":"2022","unstructured":"Zeppenfeld\u00a0K et\u00a0al (2022) 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart\u00a0J 43:3997\u20134126","journal-title":"Eur Heart J"},{"key":"5296_CR9","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1161\/CIRCULATIONAHA.117.030834","volume":"137","author":"N Frey","year":"2018","unstructured":"Frey\u00a0N et\u00a0al (2018) Left ventricular biopsy in the diagnosis of myocardial diseases. Circulation 137:993\u2013995","journal-title":"Circulation"},{"key":"5296_CR10","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s00059-017-4583-0","volume":"42","author":"B Stallmeyer","year":"2017","unstructured":"Stallmeyer\u00a0B et\u00a0al (2017) Molecular genetic diagnostics for ventricular arrhythmias and sudden cardiac death syndromes. Herz 42:476\u2013484","journal-title":"Herz"},{"key":"5296_CR11","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1093\/eurheartj\/ehu301","volume":"36","author":"J Haas","year":"2015","unstructured":"Haas\u00a0J et\u00a0al (2015) Atlas of the clinical genetics of human dilated cardiomyopathy. Eur Heart\u00a0J 36:1123\u2013135a","journal-title":"Eur Heart J"},{"key":"5296_CR12","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s12181-023-00622-3","volume":"17","author":"E Schulze-Bahr","year":"2023","unstructured":"Schulze-Bahr\u00a0E et\u00a0al (2023) Gendiagnostik bei kardiovaskul\u00e4ren Erkrankungen. Kardiologie 17:300\u2013349","journal-title":"Kardiologie"},{"key":"5296_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s11897-015-0264-6","volume":"12","author":"E Kayvanpour","year":"2015","unstructured":"Kayvanpour\u00a0E et\u00a0al (2015) Determined to fail\u2014the role of genetic mechanisms in heart failure. Curr Heart Fail Rep 12:333\u2013338","journal-title":"Curr Heart Fail Rep"},{"key":"5296_CR14","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1007\/s00392-023-02310-4","volume":"113","author":"A Amr","year":"2024","unstructured":"Amr\u00a0A et\u00a0al (2024) Improving sudden cardiac death risk stratification in hypertrophic cardiomyopathy using established clinical variables and genetic information. Clin Res Cardiol 113:728\u2013736","journal-title":"Clin Res Cardiol"},{"key":"5296_CR15","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","volume":"35","author":"C O\u2019Mahony","year":"2014","unstructured":"O\u2019Mahony\u00a0C et\u00a0al (2014) A\u00a0novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). Eur Heart\u00a0J 35:2010\u20132020","journal-title":"Eur Heart J"},{"key":"5296_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ijcard.2021.07.002","volume":"339","author":"E Kayvanpour","year":"2021","unstructured":"Kayvanpour\u00a0E et\u00a0al (2021) A\u00a0novel risk model for predicting potentially life-threatening arrhythmias in non-ischemic dilated cardiomyopathy (DCM-SVA risk). Int J Cardiol 339:75\u201382","journal-title":"Int J Cardiol"},{"key":"5296_CR17","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","volume":"44","author":"TA McDonagh","year":"2023","unstructured":"McDonagh\u00a0TA et\u00a0al (2023) 2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC) with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart\u00a0J 44:3627\u20133639","journal-title":"Eur Heart J"},{"key":"5296_CR18","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","volume":"396","author":"I Olivotto","year":"2020","unstructured":"Olivotto\u00a0I et\u00a0al (2020) Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (Explorer-HCM): a\u00a0randomised, double-blind, placebo-controlled, phase\u00a03\u00a0trial. Lancet 396:759\u2013769","journal-title":"Lancet"},{"key":"5296_CR19","doi-asserted-by":"publisher","unstructured":"IQWiG Mavacamten (Kardiomyopathie) \u2013 Nutzenbewertung gem\u00e4\u00df \u00a7\u00a035a\u00a0SGB\u00a0V https:\/\/doi.org\/10.60584\/A23-76","DOI":"10.60584\/A23-76"},{"key":"5296_CR20","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","volume":"379","author":"MS Maurer","year":"2018","unstructured":"Maurer\u00a0MS et\u00a0al (2018) Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N\u00a0Engl J Med 379:1007\u20131016","journal-title":"N Engl J Med"},{"key":"5296_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1716153","volume":"379","author":"D Adams","year":"2018","unstructured":"Adams\u00a0D et\u00a0al (2018) Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N\u00a0Engl J Med 379:11\u201321","journal-title":"N Engl J Med"},{"key":"5296_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13506129.2022.2091985","volume":"30","author":"D Adams","year":"2023","unstructured":"Adams\u00a0D et\u00a0al (2023) Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a\u00a0randomized clinical trial. Amyloid 30:1\u20139","journal-title":"Amyloid"},{"key":"5296_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2024.11.015","author":"M Fontana","year":"2024","unstructured":"Fontana\u00a0M et\u00a0al (2024) Outpatient worsening heart failure in patients with transthyretin amyloidosis with cardiomyopathy in the HELIOS\u2011B trial. J\u00a0Am Coll Cardiol. https:\/\/doi.org\/10.1016\/j.jacc.2024.11.015","journal-title":"J Am Coll Cardiol"},{"key":"5296_CR24","unstructured":"Intella-Therapeutics Intellia therapeutics announces first patient dosed in the phase\u00a03 magnitude study of NTLA-2001 as a\u00a0single-dose CRISPR-based treatment for transthyretin amyloidosis with cardiomyopathy. https:\/\/ir.intelliatx.com\/news-releases\/news-release-details\/intellia-therapeutics-announces-first-patient-dosed-phase-3;. Zugegriffen: 1. Nov. 2023"},{"key":"5296_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1056\/NEJMoa2303765","volume":"389","author":"P Garcia-Pavia","year":"2023","unstructured":"Garcia-Pavia\u00a0P et\u00a0al (2023) Phase\u00a01 trial of antibody NI006 for depletion of cardiac transthyretin amyloid. N\u00a0Engl J Med 389:239\u2013250","journal-title":"N Engl J Med"},{"key":"5296_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10184101","author":"J Koelemen","year":"2021","unstructured":"Koelemen\u00a0J et\u00a0al (2021) RBM20-related cardiomyopathy: current understanding and future options. J\u00a0Clin Med. https:\/\/doi.org\/10.3390\/jcm10184101","journal-title":"J Clin Med"},{"key":"5296_CR27","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/nm.2693","volume":"18","author":"W Guo","year":"2012","unstructured":"Guo\u00a0W et\u00a0al (2012) RBM20, a\u00a0gene for hereditary cardiomyopathy, regulates titin splicing. Nat Med 18:766\u2013773","journal-title":"Nat Med"},{"key":"5296_CR28","doi-asserted-by":"publisher","first-page":"eade1633","DOI":"10.1126\/scitranslmed.ade1633","volume":"14","author":"T Nishiyama","year":"2022","unstructured":"Nishiyama\u00a0T et\u00a0al (2022) Precise genomic editing of pathogenic mutations in RBM20 rescues dilated cardiomyopathy. Sci Transl Med 14:eade1633","journal-title":"Sci Transl Med"},{"key":"5296_CR29","doi-asserted-by":"publisher","first-page":"eabd3079","DOI":"10.1126\/scitranslmed.abd3079","volume":"13","author":"A Fomin","year":"2021","unstructured":"Fomin\u00a0A et\u00a0al (2021) Truncated titin proteins and titin haploinsufficiency are targets for functional recovery in human cardiomyopathy due to TTN mutations. Sci Transl Med 13:eabd3079","journal-title":"Sci Transl Med"},{"key":"5296_CR30","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1016\/j.jacc.2018.08.2181","volume":"72","author":"F Dom\u00ednguez","year":"2018","unstructured":"Dom\u00ednguez\u00a0F et\u00a0al (2018) Dilated cardiomyopathy due to BLC2-associated athanogene 3 (BAG3) mutations. J\u00a0Am Coll Cardiol 72:2471\u20132481","journal-title":"J Am Coll Cardiol"},{"key":"5296_CR31","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.jacbts.2016.08.008","volume":"1","author":"T Knezevic","year":"2016","unstructured":"Knezevic\u00a0T et\u00a0al (2016) Adeno-associated virus serotype 9\u2014driven expression of BAG3 improves left ventricular function in murine hearts with left ventricular dysfunction secondary to a\u00a0myocardial infarction. JACC Basic Transl Sci 1:647\u2013656","journal-title":"JACC Basic Transl Sci"},{"key":"5296_CR32","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1038\/s41588-024-01975-5","volume":"56","author":"SJ Jurgens","year":"2024","unstructured":"Jurgens\u00a0SJ et\u00a0al (2024) Genome-wide association study reveals mechanisms underlying dilated cardiomyopathy and myocardial resilience. Nat Genet 56:2636\u20132645","journal-title":"Nat Genet"},{"key":"5296_CR33","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41569-021-00566-9","volume":"18","author":"CS Weldy","year":"2021","unstructured":"Weldy\u00a0CS et\u00a0al (2021) Towards precision medicine in heart failure. Nat Rev Cardiol 18:745\u2013762","journal-title":"Nat Rev Cardiol"},{"key":"5296_CR34","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1038\/537S49a","volume":"537","author":"R Hodson","year":"2016","unstructured":"Hodson\u00a0R (2016) Precision medicine. Nature 537:S49","journal-title":"Nature"},{"key":"5296_CR35","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S0140-6736(19)31721-0","volume":"394","author":"ZI Attia","year":"2019","unstructured":"Attia\u00a0ZI et\u00a0al (2019) An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a\u00a0retrospective analysis of outcome prediction. Lancet 394:861\u2013867","journal-title":"Lancet"},{"key":"5296_CR36","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41586-020-2145-8","volume":"580","author":"D Ouyang","year":"2020","unstructured":"Ouyang\u00a0D et\u00a0al (2020) Video-based AI for beat-to-beat assessment of cardiac function. Nature 580:252\u2013256","journal-title":"Nature"},{"key":"5296_CR37","doi-asserted-by":"publisher","first-page":"e407","DOI":"10.1016\/S2589-7500(24)00063-3","volume":"6","author":"DH Lehmann","year":"2024","unstructured":"Lehmann\u00a0DH et\u00a0al (2024) Prediction of diagnosis and diastolic filling pressure by AI-enhanced cardiac MRI: a\u00a0modelling study of hospital data. Lancet Digit Health 6:e407\u201317","journal-title":"Lancet Digit Health"},{"key":"5296_CR38","doi-asserted-by":"publisher","first-page":"7255","DOI":"10.1007\/s00330-024-10794-5","volume":"34","author":"S Schalekamp","year":"2024","unstructured":"Schalekamp\u00a0S et\u00a0al (2024) Performance of AI to exclude normal chest radiographs to reduce radiologists\u2019 workload. Eur Radiol 34:7255\u20137263","journal-title":"Eur Radiol"},{"key":"5296_CR39","doi-asserted-by":"publisher","first-page":"e230860","DOI":"10.1148\/radiol.230860","volume":"309","author":"S Bennani","year":"2023","unstructured":"Bennani\u00a0S et\u00a0al (2023) Using AI to improve radiologist performance in detection of abnormalities on chest radiographs. Radiology 309:e230860","journal-title":"Radiology"},{"key":"5296_CR40","doi-asserted-by":"publisher","first-page":"e2440969","DOI":"10.1001\/jamanetworkopen.2024.40969","volume":"7","author":"E Goh","year":"2024","unstructured":"Goh\u00a0E et\u00a0al (2024) Large language model influence on diagnostic reasoning: a\u00a0randomized clinical trial. JAMA Netw Open 7:e2440969","journal-title":"JAMA Netw Open"},{"key":"5296_CR41","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper\u00a0J et\u00a0al (2021) Highly accurate protein structure prediction with AlphaFold. Nature 596:583\u2013589","journal-title":"Nature"},{"key":"5296_CR42","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.123.066961","author":"D Kehr","year":"2024","unstructured":"Kehr\u00a0D et\u00a0al (2024) S100A1ct: a\u00a0synthetic peptide derived from S100A1 protein improves cardiac performance and survival in preclinical heart failure models. Circulation. https:\/\/doi.org\/10.1161\/circulationaha.123.066961","journal-title":"Circulation"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-025-05296-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00059-025-05296-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-025-05296-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T15:46:48Z","timestamp":1748965608000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00059-025-05296-z"}},"subtitle":["State of the Art","State of the art"],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["5296"],"URL":"https:\/\/doi.org\/10.1007\/s00059-025-05296-z","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"3 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"N.\u00a0Vetter gibt an, dass kein Interessenkonflikt besteht. B.\u00a0Meder: Scientific Advisory Honoaria: Fleischhacker GmbH, MyoKardia, Bristol-Myers Squibb, Cytokinetics, Novo Nordisk; Research Cooperation & Research Support: Apple Inc., Daiichi Sankyo, Siemens Healthineers, Novo Nordisk, Bristol-Myers Squibb; Speaker Honoraria or Travel Support: Daiichi Sankyo, Bristol-Myers Squibb, Boston Scientific, SMT, Amgen, Bayer AG, Pfizer, AstraZeneca, Deutsche Gesellschaft f\u00fcr Kardiologie, BNK, Novartis; Patent applications & patents on miRNA and DNA methylation: UKHD, Siemens Healthineers, Hummingbird Diagnostics; Board Member: Informatics for Life, Deutsche Gesellschaft f\u00fcr Kardiologie, ESC Myocardial Disease WG; AG\u00a012 Kardiomyopathien (Past-Sprecher, Nukleus); ESC Working Group Pericardial and Myocardial Diseases; Institute for Cardiomyopathies Heidelberg and Cardiogenetics Center Heidelberg.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}